SM
ACIU icon

Scoggin Management’s AC Immune ACIU Stock Holding History

Scoggin Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-84,401
Closed -$250K – 61
2024
Q1 		$250K Buy
+84,401
New +$303K 0.09% 58

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Scoggin Management's ACIU Position: Q2 2024 in Review

Scoggin Management sold out of AC Immune (ACIU) in Q2 2024, closing a stake of 84,401 shares — an estimated $250K sold.

Scoggin Management first reported a position in ACIU in Q1 2024 and held it in 1 quarter. The position peaked at $250K in Q1 2024. 45 funds tracked by Wall St. Rank hold ACIU as of Q2 2024.

  • Scoggin Management reported no remaining AC Immune position as of Q2 2024 after selling out during the quarter.
  • Scoggin Management sold 84,401 AC Immune shares in Q2 2024, an estimated $250K.
  • Scoggin Management first reported a position in AC Immune in Q1 2024 and held it in 1 quarter.
  • Scoggin Management's AC Immune position peaked at $250K in Q1 2024.
  • 45 funds tracked by Wall St. Rank held AC Immune as of Q2 2024.

Based on Scoggin Management's 13F filing for Q2 2024, filed 14 Aug 2024.